Human Embryonic Stem Cell Derived Retinal Pigment Epithelium (RPE) for retinitis pigmentosa

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 1 trial. Early trial in people, checking safety. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 24 May 2019: Trial registered, NCT03963154
  2. 19 Aug 2019: Trial started, NCT03963154

The trials

NCT03963154: Interventional Study of Implantation of hESC-derived RPE in Patients With RP Due to Monogenic Mutation

State
Under way
Phase
Phase 1 and Phase 2
People
7 taking part
Started
19 Aug 2019
Primary completion
22 Jun 2023
Arms
Implantation of a therapeutical patch
Results
None posted
  1. 24 May 2019: Trial registered
  2. 19 Aug 2019: Trial started

How the status changed

  1. 19 Nov 2026: First set: Phase 1 trial

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.